//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Noxopharm has announced positive results from InhaTarget Therapeutics, a company with a unique inhalation-based delivery system that is testing Sofra™ technology platform assets. Read the announcement here: www.noxopharm.com/pdf/deb770c3...
1mo
www.noxopharm.com